We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 225 results
  1. [68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserve

    Background

    Determination of the functional liver mass is important in a variety of clinical settings including liver surgery and transplantation. [ 99m ...

    Maximilian A. Zierke, Christine Rangger, ... Roland Haubner in EJNMMI Radiopharmacy and Chemistry
    Article Open access 15 May 2024
  2. Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells

    Purpose

    Positron emission tomography (PET) with specific diagnostic probes for quantifying CD8 + T cells has emerged as a powerful technique for...

    Yan Wang, Chao Wang, ... Liyan Miao in European Journal of Nuclear Medicine and Molecular Imaging
    Article 13 July 2022
  3. PET imaging of an optimized anti-PD-L1 probe 68Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates

    Background

    Adnectin is a protein family derived from the 10th type III domain of human fibronectin ( 10 Fn3) with high-affinity targeting capabilities....

    Huimin Zhou, Guangfa Bao, ... **aohua Zhu in EJNMMI Research
    Article Open access 13 June 2022
  4. Comparison of integrin αvβ3 expression with 68Ga-NODAGA-RGD PET/CT and glucose metabolism with 18F-FDG PET/CT in esophageal or gastroesophageal junction cancers

    Background

    The primary aims of this study were to compare in patients with esophageal or esophagogastric junction cancers the potential of 68 Ga-NODAGA...

    Matthieu Dietz, Vincent Dunet, ... John O. Prior in European Journal of Hybrid Imaging
    Article Open access 01 February 2023
  5. Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease

    Background

    Integrin alpha-V-beta-3 (αvβ3) pathway is involved in intraplaque angiogenesis and inflammation and represents a promising target for...

    Matthieu Dietz, Christel H. Kamani, ... John O. Prior in EJNMMI Research
    Article Open access 14 August 2021
  6. A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE

    Purpose

    The purpose of this study is to evaluate the diagnostic efficacy of 68  Ga-NODAGA-LM3 and 68  Ga-DOTA-LM3 and compare them with 68 Ga-DOTATATE...

    Article 07 December 2021
  7. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure

    Background

    Angiogenesis has increasingly been a target for imaging and treatment over the last decade. The integrin α v β 3 is highly expressed in cells...

    Simon Bentsen, Jacob Kildevang Jensen, ... Andreas Kjaer in Journal of Nuclear Cardiology
    Article Open access 01 May 2023
  8. Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China

    Purpose

    Somatostatin receptor antagonists have shown promising performance for imaging neuroendocrine neoplasms. However, there is a lack of studies...

    Meixi Liu, Yuejuan Cheng, ... Li Huo in European Journal of Nuclear Medicine and Molecular Imaging
    Article 10 February 2024
  9. Development of New CD38 Targeted Peptides for Cancer Imaging

    Purpose

    Multiple myeloma (MM) affects over 35,000 patients each year in the US. There remains a need for versatile Positron Emission Tomography (PET)...

    Alexander Zheleznyak, Rui Tang, ... Monica Shokeen in Molecular Imaging and Biology
    Article Open access 13 March 2024
  10. Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study

    Background

    Angiogenesis plays an important role in head and neck squamous cell carcinoma (HNSCC) progression. This pilot study was designed to compare...

    Steve Durante, Vincent Dunet, ... John O. Prior in EJNMMI Research
    Article Open access 07 May 2020
  11. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 PET and hyperpolarized [1-13C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect

    Purpose

    Cancer has a multitude of phenotypic expressions and identifying these are important for correct diagnosis and treatment selection. Clinical...

    Andreas Clemmensen, Adam E Hansen, ... Andreas Kjaer in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 03 July 2020
  12. Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections

    Background

    The urgent demand for innovative theranostic strategies to combat bacterial resistance to antibiotics is evident, with substantial...

    Jyotsna Bhatt Mitra, Saurav Chatterjee, ... Archana Mukherjee in EJNMMI Radiopharmacy and Chemistry
    Article Open access 26 March 2024
  13. Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules

    Background

    Extrapolation of human absorbed doses (ADs) from biodistribution experiments on laboratory animals is used to predict the efficacy and...

    Francesco Cicone, David Viertl, ... Silvano Gnesin in EJNMMI Research
    Article Open access 11 April 2022
  14. Development and Preclinical Evaluation of 99mTc- and 186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors

    Purpose

    The goal of this work was to develop hydrophilic gastrin-releasing peptide receptor (GRPR)-targeting complexes of the general formula fac -[M(CO)...

    George Makris, Rajendra P. Bandari, ... Heather M. Hennkens in Molecular Imaging and Biology
    Article 04 September 2020
  15. A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides

    Purpose

    The angiotensin converting enzyme-2 (ACE2)—entry receptor of SARS-CoV-2—and its homologue, the angiotensin-converting enzyme (ACE), play a...

    Darja Beyer, Christian Vaccarin, ... Cristina Müller in EJNMMI Research
    Article Open access 19 April 2023
  16. Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry

    Background

    44 Sc/ 47 Sc is an attractive theranostic pair for targeted in vivo positron emission tomographic (PET) imaging and beta-particle treatment...

    Nadia Benabdallah, Hanwen Zhang, ... Daniel L. J. Thorek in EJNMMI Research
    Article Open access 28 February 2023
  17. A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases

    Purpose

    Prostate cancer (PCa) commonly metastasizes to the bones. There are several radionuclide techniques for imaging PCa skeletal metastases. We...

    Ismaheel O. Lawal, Kgomotso M. G. Mokoala, ... Mike M. Sathekge in European Journal of Nuclear Medicine and Molecular Imaging
    Article 18 May 2020
  18. Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial

    Purpose

    18 F-labelled somatostatin receptor (SSTR) analogs offer several advantages over 68 Ga in terms of yield, cost, spatial resolution and...

    Article 15 June 2024
  19. Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4

    Introduction

    Radiolabeled exendin-4 (Ex4) derivatives are used to target the glucagon-like peptide-1 receptor (GLP-1R) for the clinical diagnosis of...

    Simon A. M. Kaeppeli, Roger Schibli, ... Martin Behe in EJNMMI Radiopharmacy and Chemistry
    Article Open access 16 May 2019
Did you find what you were looking for? Share feedback.